Amgen Historical Financial Ratios

AMGN Stock

USD 273.65 2.10 0.76%

Amgen is presently reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0185, PTB Ratio of 25.96 or Days Sales Outstanding of 108 will help investors to properly organize and evaluate Amgen Inc financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

About Amgen Financial Ratios Analysis

Amgen IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Amgen investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Amgen financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Amgen history.

Amgen Financial Ratios Chart

At this time, Amgen's EV To Sales is very stable compared to the past year. As of the 11th of December 2024, Free Cash Flow Per Share is likely to grow to 14.44, while Dividend Yield is likely to drop 0.02.

Dividend Yield Capex To Depreciation Interest Coverage Capex To Operating Cash Flow Ev To Free Cash Flow Price Earnings To Growth Ratio

Add Fundamental

Dividend Yield

Dividend Yield is Amgen Inc dividend as a percentage of Amgen stock price. Amgen Inc dividend yield is a measure of Amgen stock productivity, which can be interpreted as interest rate earned on an Amgen investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Most ratios from Amgen's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Amgen Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

	2021	2022	2023	2024 (projected)
Dividend Yield	0.0313	0.0297	0.0296	0.0185
Price To Sales Ratio	4.94	5.37	5.47	9.47

Dividend Yield Price To Sales Ratio

Amgen fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		-0.42	0.0	-0.04	-0.53	-0.96	-0.46	0.89	0.0	0.99	-0.47	-0.45	0.91	-0.37	-0.81	0.26	0.92	-0.4	-0.88	-0.76	-0.19	-0.91	-0.64	-0.14	-0.21	-0.13
Dividend Yield	-0.42		0.55	0.29	-0.02	0.45	0.88	-0.54	0.55	-0.36	0.88	0.39	-0.48	0.69	0.24	0.03	-0.5	0.27	0.48	0.23	0.56	0.48	0.41	-0.04	0.25	0.6
Ptb Ratio	0.0	0.55		0.77	-0.63	-0.04	0.63	-0.25	1.0	0.05	0.59	0.3	-0.2	0.65	0.16	0.02	-0.2	-0.17	0.25	-0.38	0.19	0.2	0.45	0.04	-0.15	0.98
Days Sales Outstanding	-0.04	0.29	0.77		-0.51	-0.01	0.46	-0.31	0.77	0.03	0.41	0.3	-0.29	0.57	0.38	-0.05	-0.27	0.08	0.35	-0.36	0.09	0.29	0.63	0.18	-0.18	0.73
Book Value Per Share	-0.53	-0.02	-0.63	-0.51		0.62	0.01	-0.43	-0.63	-0.5	0.03	0.04	-0.46	-0.15	0.21	-0.17	-0.47	0.67	0.43	0.77	0.17	0.47	0.19	0.08	0.39	-0.57
Free Cash Flow Yield	-0.96	0.45	-0.04	-0.01	0.62		0.56	-0.92	-0.04	-0.94	0.57	0.51	-0.93	0.4	0.68	-0.42	-0.94	0.55	0.9	0.84	0.29	0.93	0.65	0.3	0.32	0.1
Operating Cash Flow Per Share	-0.46	0.88	0.63	0.46	0.01	0.56		-0.73	0.63	-0.38	1.0	0.61	-0.67	0.83	0.29	-0.24	-0.68	0.38	0.69	0.3	0.51	0.67	0.69	0.24	0.23	0.7
Capex To Depreciation	0.89	-0.54	-0.25	-0.31	-0.43	-0.92	-0.73		-0.25	0.83	-0.72	-0.64	0.99	-0.63	-0.72	0.39	1.0	-0.52	-0.99	-0.68	-0.3	-0.99	-0.89	-0.32	-0.22	-0.37
Pb Ratio	0.0	0.55	1.0	0.77	-0.63	-0.04	0.63	-0.25		0.05	0.59	0.3	-0.2	0.65	0.16	0.02	-0.2	-0.17	0.25	-0.38	0.19	0.2	0.45	0.04	-0.15	0.98
Ev To Sales	0.99	-0.36	0.05	0.03	-0.5	-0.94	-0.38	0.83	0.05		-0.39	-0.41	0.86	-0.3	-0.78	0.27	0.86	-0.31	-0.82	-0.76	-0.13	-0.86	-0.55	-0.12	-0.18	-0.09
Free Cash Flow Per Share	-0.47	0.88	0.59	0.41	0.03	0.57	1.0	-0.72	0.59	-0.39		0.6	-0.65	0.81	0.27	-0.25	-0.68	0.37	0.68	0.34	0.52	0.66	0.65	0.24	0.25	0.66
Roic	-0.45	0.39	0.3	0.3	0.04	0.51	0.61	-0.64	0.3	-0.41	0.6		-0.62	0.83	0.35	-0.42	-0.63	0.15	0.65	0.45	-0.2	0.62	0.65	0.39	-0.34	0.46
Inventory Turnover	0.91	-0.48	-0.2	-0.29	-0.46	-0.93	-0.67	0.99	-0.2	0.86	-0.65	-0.62		-0.58	-0.76	0.42	1.0	-0.53	-1.0	-0.69	-0.26	-1.0	-0.88	-0.35	-0.21	-0.32
Net Income Per Share	-0.37	0.69	0.65	0.57	-0.15	0.4	0.83	-0.63	0.65	-0.3	0.81	0.83	-0.58		0.33	-0.09	-0.58	0.15	0.61	0.16	-0.02	0.58	0.69	0.1	-0.33	0.77
Days Of Inventory On Hand	-0.81	0.24	0.16	0.38	0.21	0.68	0.29	-0.72	0.16	-0.78	0.27	0.35	-0.76	0.33		-0.23	-0.74	0.3	0.74	0.44	0.1	0.75	0.65	0.18	0.07	0.25
Payables Turnover	0.26	0.03	0.02	-0.05	-0.17	-0.42	-0.24	0.39	0.02	0.27	-0.25	-0.42	0.42	-0.09	-0.23		0.42	-0.33	-0.41	-0.44	-0.26	-0.41	-0.39	-0.98	-0.38	-0.03
Capex To Revenue	0.92	-0.5	-0.2	-0.27	-0.47	-0.94	-0.68	1.0	-0.2	0.86	-0.68	-0.63	1.0	-0.58	-0.74	0.42		-0.52	-0.99	-0.71	-0.28	-1.0	-0.87	-0.34	-0.22	-0.32
Cash Per Share	-0.4	0.27	-0.17	0.08	0.67	0.55	0.38	-0.52	-0.17	-0.31	0.37	0.15	-0.53	0.15	0.3	-0.33	-0.52		0.52	0.51	0.45	0.53	0.46	0.35	0.5	-0.15
Pocfratio	-0.88	0.48	0.25	0.35	0.43	0.9	0.69	-0.99	0.25	-0.82	0.68	0.65	-1.0	0.61	0.74	-0.41	-0.99	0.52		0.65	0.26	1.0	0.92	0.36	0.19	0.36
Interest Coverage	-0.76	0.23	-0.38	-0.36	0.77	0.84	0.3	-0.68	-0.38	-0.76	0.34	0.45	-0.69	0.16	0.44	-0.44	-0.71	0.51	0.65		0.22	0.69	0.36	0.31	0.36	-0.24
Payout Ratio	-0.19	0.56	0.19	0.09	0.17	0.29	0.51	-0.3	0.19	-0.13	0.52	-0.2	-0.26	-0.02	0.1	-0.26	-0.28	0.45	0.26	0.22		0.26	0.19	0.29	0.91	0.11
Capex To Operating Cash Flow	-0.91	0.48	0.2	0.29	0.47	0.93	0.67	-0.99	0.2	-0.86	0.66	0.62	-1.0	0.58	0.75	-0.41	-1.0	0.53	1.0	0.69	0.26		0.88	0.34	0.21	0.32
Pfcf Ratio	-0.64	0.41	0.45	0.63	0.19	0.65	0.69	-0.89	0.45	-0.55	0.65	0.65	-0.88	0.69	0.65	-0.39	-0.87	0.46	0.92	0.36	0.19	0.88		0.4	0.05	0.52
Days Payables Outstanding	-0.14	-0.04	0.04	0.18	0.08	0.3	0.24	-0.32	0.04	-0.12	0.24	0.39	-0.35	0.1	0.18	-0.98	-0.34	0.35	0.36	0.31	0.29	0.34	0.4		0.37	0.07
Income Quality	-0.21	0.25	-0.15	-0.18	0.39	0.32	0.23	-0.22	-0.15	-0.18	0.25	-0.34	-0.21	-0.33	0.07	-0.38	-0.22	0.5	0.19	0.36	0.91	0.21	0.05	0.37		-0.23
Roe	-0.13	0.6	0.98	0.73	-0.57	0.1	0.7	-0.37	0.98	-0.09	0.66	0.46	-0.32	0.77	0.25	-0.03	-0.32	-0.15	0.36	-0.24	0.11	0.32	0.52	0.07	-0.23

Click cells to compare fundamentals

Amgen Account Relationship Matchups

Amgen fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	6.24	5.3	4.94	5.37	5.47	9.47
Dividend Yield	0.0241	0.0279	0.0313	0.0297	0.0296	0.0185
Ptb Ratio	15.08	14.32	19.14	38.6	24.73	25.96
Days Sales Outstanding	63.39	64.96	68.77	77.14	102.83	107.97
Book Value Per Share	15.99	16.06	11.75	6.8	11.65	10.26
Free Cash Flow Yield	0.0585	0.0734	0.0654	0.0622	0.0478	0.0377
Operating Cash Flow Per Share	15.12	17.91	16.25	18.07	15.83	16.63
Stock Based Compensation To Revenue	0.0131	0.0132	0.013	0.0152	0.0153	0.0186
Capex To Depreciation	0.34	0.38	0.28	0.17	0.26	0.27
Pb Ratio	15.08	14.32	19.14	38.6	24.73	25.96
Ev To Sales	6.55	7.26	6.35	5.91	6.56	9.89
Free Cash Flow Per Share	14.1	16.88	14.7	16.33	13.76	14.44
Inventory Turnover	1.39	1.22	1.58	1.3	0.88	0.84
Net Income Per Share	12.96	12.4	10.34	12.18	12.56	13.18
Days Of Inventory On Hand	300.31	230.71	231.08	280.9	412.84	217.1
Payables Turnover	3.18	4.33	4.72	4.08	5.29	2.98
Capex To Revenue	0.0265	0.0239	0.0339	0.0356	0.0394	0.0375
Cash Per Share	14.73	18.17	14.1	17.3	40.91	42.96
Pocfratio	15.94	12.84	13.85	14.54	18.19	24.53
Interest Coverage	7.51	4.59	5.02	3.79	2.75	2.61
Payout Ratio	1.7	0.42	0.45	0.52	0.68	0.64
Capex To Operating Cash Flow	0.0675	0.0579	0.095	0.0963	0.13	0.22
Pfcf Ratio	17.09	13.62	15.3	16.08	20.94	28.6
Days Payables Outstanding	114.88	84.21	77.25	89.57	68.97	131.01
Income Quality	1.17	1.45	1.57	1.48	1.26	1.1
Roe	0.81	0.77	0.88	1.79	1.08	1.13
Ev To Operating Cash Flow	13.78	18.55	15.38	17.76	24.53	26.22
Pe Ratio	18.6	18.55	21.76	21.57	22.94	21.79
Ev To Free Cash Flow	19.89	16.33	18.32	19.65	28.23	30.51
Earnings Yield	0.0538	0.0539	0.046	0.0464	0.0436	0.0302
Intangibles To Total Assets	0.33	0.57	0.5	0.49	0.53	0.47
Net Debt To E B I T D A	2.09	1.89	2.07	2.02	2.59	3.65
Current Ratio	1.44	1.81	1.59	1.41	1.65	1.57
Tangible Book Value Per Share	(40.4)	(37.32)	(41.0)	(51.95)	(84.18)	(79.97)
Receivables Turnover	5.76	5.62	5.31	4.73	3.55	3.37
Graham Number	68.29	66.92	52.29	43.18	57.36	60.23

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amgen Stock

0.9	VALN	Valneva SE ADR	Pair Corr
0.9	ERNA	Eterna Therapeutics	Pair Corr

Moving against Amgen Stock

0.85	BMY	Bristol Myers Squibb	Pair Corr
0.82	ESPR	Esperion Therapeutics	Pair Corr
0.68	DYAI	Dyadic International	Pair Corr
0.6	GILD	Gilead Sciences	Pair Corr
0.41	DNA	Ginkgo Bioworks Holdings	Pair Corr

The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.

The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:

How To Invest In Amgen

Details

Is Amgen Stock a good investment?

Details

What is Amgen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.621

Dividend Share

8.88

Earnings Share

7.83

Revenue Per Share

60.641

Quarterly Revenue Growth

0.232

The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Amgen Historical Financial Ratios

About Amgen Financial Ratios Analysis

Amgen Financial Ratios Chart

Dividend Yield

Capex To Depreciation

Ev To Free Cash Flow

Amgen fundamentals Correlations

Amgen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Amgen fundamentals Accounts

Pair Trading with Amgen

Moving together with Amgen Stock

Moving against Amgen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Capex To Revenue	+ 1.0	Capex To Depreciation
Capex To Revenue	+ 1.0	Inventory Turnover
Capex To Operating Cash Flow	+ 1.0	Pocfratio
Ev To Sales	+ 0.99	Price To Sales Ratio

Capex To Operating Cash Flow	- 1.0	Capex To Revenue
Capex To Operating Cash Flow	- 1.0	Inventory Turnover
Pocfratio	- 1.0	Inventory Turnover
Pocfratio	- 0.99	Capex To Revenue
Capex To Operating Cash Flow	- 0.99	Capex To Depreciation
Pocfratio	- 0.99	Capex To Depreciation